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Elucidation of the Signaling Pathway of MERTK

Kyle Taruc

Abstract
Mer tyrosine kinase (MERTK) is a receptor tyrosine kinase which mediates efferocytosis-the
recognition and uptake of apoptotic cells. MERTK serves as the predominant efferocytic
receptor in several tissues, including in the heart, with single nucleotide polymorphisms
associated with up to a 75% increased risk of atherosclerosis in humans. MERTK facilitates the
internalization of apoptotic cells via a MERTK/integrin pathway that involves, in part, PI-3kinase signaling and signaling via Src-family kinases. While these elements of the MERTK
signaling pathway have been identified, much of MERTK’s signaling mechanisms remain to be
elucidated. Pharmacological inhibitors were used to block signaling through canonical
phagocytic signaling pathways, and through signalling molecules identified as part of the
MERTK signalosome by mass spectrometry, and the efferocytosis of MERTK-specific targets
assessed using a human macrophage cell line. These experiments identified PI3K, Src, Syk,
ERK, and ILK as regulators of MERTK efferocytic function. To identify non-canonical
pathways, we began the development of a CRISPR-tagged endogenous MERTK allele which can
be selectively activated in a human macrophage cell line without inadvertent activation of other
phagocytic receptors; using this cell line and phosphoprotein mass spectrometry, future studies
will be able to identify non-canonical tyrosine-kinase dependent pathways mediating MERTK
efferocytic function. Identification of these pathways will elucidate the signaling pathway
utilized by MERTK, and potentially may identify signaling pathways which drive aberrant
MERTK function during diseases such as atherosclerosis.

Keywords
Cell Signalling, Cross-link, CRISPR, Cas9, Efferocytosis, Fluorescence Microscopy, Growth
arrest-specific 6, Macrophage, MER tyrosine kinase (MERTK), Phagocyte, Phagocytosis,
Immunoprecipitation.
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Chapter 1

1

Introduction

1.1

Apoptosis and Efferocytosis

Apoptosis, or programmed cell death, is a highly regulated physiological process that is essential
for the development and maintenance of homeostasis in multicellular organisms1. It is a
prerequisite for the removal of infected or damaged cells from host tissues. Tens of billions of
cells undergo apoptosis on a daily basis within the human body, a phenomenon that is usually
counterbalanced by efferocytosis - the phagocytic clearance of apoptotic cells1. Together,
apoptosis and effeorcytosis facilitate the removal of apoptotic cell debris from healthy
individuals in order to maintain homeostasis1. If efferocytosis is impaired, however, uncleared
apoptotic cells accumulate, lyse through secondary necrosis, and release their intracellular
contents into the extracellular milieu. These newly-released intracellular molecules are
proinflammatory and can induce pathological conditions such as autoimmunity and chronic
inflammatory disease1. Apoptotic cells are recognized by efferocytic cells via “eat-me” signals
such as phosphatidylserine (PtdSer) exposed on the surface of apoptotic cells. PtdSer is the
primary eat-me signal for efferocytosis. Normally, PtdSer is confined to the inner portion of the
plasma membrane, but in cell undergoing apoptosis, it accumulates on the outer leaflet of the
membrane because of inactivation of flippase proteins which are responsible for maintaining
membrane lipid asymmetry, coupled with activation of scramblases that disrupt asymmetry2.
Exposed PtdSer is recognized by an array of efferocytic receptors expressed by both professional
phagocytes such as macrophages and dendritic cells, and by non-professional phagocytes such as
epithelial cells which then proceed to engulf and degrade the apoptotic cell3–6.
Efferocytosis is an inherently anti-inflammatory process that is associated with the release of
anti-inflammatory and pro-resolving cytokines such as interleukin-10 (IL-10) and transforming
growth factor beta (TGFβ)7. These factors not only inhibit the inflammatory response, but also
promote increased tissue regeneration and wound healing8. Macrophages exhibit an inherent
1
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phenotypic plasticity in response to the specific types of pro- or anti-inflammatory cytokines and
chemokines present in the extracellular milieu. Stimulation by cytokines such as granulocytemonocyte colony-stimulating factor (GM-CSF), and interferon gamma (IFN γ), or activation of
toll-like receptor (TLR) and ligands such as lipopolysaccharide (LPS), results in the polarization
of macrophages into a pro-inflammatory M1 phenotype9. M1 macrophages are primarily
characterized by upregulated pro-inflammatory cytokine production, reactive oxygen species
(ROS) production, and phagocytic activity9, but are impaired in their ability to mediate
efferocytosis due to decreased peroxisome proliferator-activated receptor gamma (PPAR γ)
activity10. PPAR γ acts as a transcription factor that interferes with inflammatory signaling
pathways such as the NF-kβ pathway, which upregulates the activity of known pro-inflammatory
cytokines TNFα and IL-1β10. In addition to repression of PPAR γ signaling, M1 macrophages
increase expression of IRF5, a transcription factor known to inhibit expression of CD36 and
CD14 efferocytic receptors while simultaneously inducing expression of pro-inflammatory
cytokines11. Alternatively, macrophages can also be polarized towards the anti-inflammatory M2
phenotype by exposure to increased levels of anti-inflammatory cytokines such as IL-4, IL-3, IL10, TGFβ, macrophage colony-stimulating factor (M-CSF), and by hormones such as
glucocorticoids9. M2 macrophages are have been observed to exhibit enhanced antiinflammatory and efferocytic activity coupled with downregulated production of proinflammatory cytokines and reactive oxygen species (ROS)9. These are mediated, in part, by an
increase in PPARγ expression and activity facilitated by upregulated IL-4 signaling to this
receptor12. Direct recognition of apoptotic cells by phagocytes also appears to induce an increase
in PPARγ activation which, in turn, is associated with M2 polarization and subsequent increases
in the expression of certain efferocytic receptors13,14.

1.2

TAM Receptors

One family of efferocytic receptors is the TAM (Tyro3, Axl, and Mertk) family of receptor
tyrosine kinases15. These receptors are known to play key roles in the maintenance of
homeostasis in fully-differentiated adult tissue15. Studies involving TAM-knockout mice that are
either lacking these receptors entirely or possess receptors with defective TKDs have shown that
2
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loss-of-function mutants, while initially viable and fertile, go on to develop debilitating
phenotypes later in life that are associated with inefficient clearance of apoptotic cells16–19. In
murine models, loss of the TAM-facilitated efferocytosis of apoptotic germ cells by Sertoli cells
during spermatogenesis results in the eventual death of all sperm progenitor cells, eventually
rendering the afflicted mouse infertile16. In the retina, retinal pigment epithelium (RPE) cells
must intermittently remove the outer, photo-damaged ends of photoreceptor cells through
MERTK or TYRO-3 mediated phagocytosis in order prevent the progression of blindness
brought about by photoreceptor death18. Disruptions in TAM signaling have been linked to the
onset of broad-spectrum autoimmune disease in mouse models17. This disease is characterized by
the clinical symptoms of both rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE)
and develops as a result of an unabated inflammatory response caused by high levels of
uncleared apoptotic cell debris17. A prolonged inflammatory response caused by deficiencies in
TAM-mediated apoptotic cell clearance has also been reported to play an important role in the
pathology of inflammatory bowel disease (IBD) 19. In nearly all of these aforementioned cases,
mutations in MERTK are associated with more severe symptoms than mutations in TYRO3 or
AXL, highlighting the importance of this receptor in the maintenance of homeostasis through
efferocytosis17. Indeed, MERTK deficiency alone is sufficient to cause blindness due to a failure
in RPE efferocytosis, and MERTK deficiency leads to autoimmunity, albeit, with later onset than
in triple-TAM knockout animals18.
Single nucleotide polymorphisms MERTK are similarly linked to human inflammatory and
autoimmune diseases. Indeed, SNPs in MERTK have strong associations with atherosclerosis,
multiple sclerosis20, lupus21 and rheumatoid arthritis22, while human MERTK deficiency is one
cause of inherited retinitis pigmentosa23. The TAM receptors do not recognize apoptotic cells
directly, and instead bind to apoptotic cells via soluble opsonins such as GAS6. As expected,
mutations in these opsonins are also associated with disease24–27. It is important to note that not
all associations between TAMs and disease are due to defects in efferocytosis. For example,
TAM receptor and Gas6 overexpression has been linked with tumor metastasis28,29. This
association is unlikely to be due to enhanced efferocytosis, and instead is thought to stem from
activation of various cell proliferation, survival, and motility signaling pathways via TAMdependent activation of Protein kinase B (Akt) and extracellular signal–regulated kinase (ERK)
28,29

.
3
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Despite the importance of MERTK and other TAM receptors in many clinical conditions,
relatively little is known about their signaling pathways. Structurally, all TAM receptors are
composed of an intracellular tyrosine kinase domain (TKD), a transmembrane domain, and an
extracellular domain composed of tandem fibronectin type III repeat domains and tandem
imunoglobulin-related (Ig) domains15 (Fig 1A). MERTK is about 150 kDA-170 kDA in size and
is composed of 999 amino acids, making it significantly larger than the other two TAM receptors
Axl and Tyro3, which are both around 120 kDA and 890 and 894 amino acids in size
respectively15. Unlike other efferocytic receptors such as those of the TIM3-4, BAI5, and Stabilin6
families, TAM receptors require Gas6 or Protein S (ProS) to act as “bridging molecules”
(opsonins) which recognize exposed phosphatidylserine (PtdSer) on the surface of apoptotic
cells15,30. Both Gas6 and ProS are 80kDA in size and are paralogs 31with 44% amino acid
similarity15. The TAM Ig domains bind to the carboxy-terminal ends of these opsonins, which
are secreted into the circulation by cells such as vascular endothelial cells and hepatocytes32.
ProS is present at a concentration of around 300 nM30 in human serum while Gas6 is present at
about 0.2 nM, with much of the Gas6 bound to a soluble Axl ectodomain33,34. Binding of these
opsonins results in the dimerization of the Ig domains and the subsequent activation of the TAM
kinase domain15. Gas6 has been observed to activate all three TAM receptors, while ProS is only
known to activate Axl and MERTK. While Axl has been shown to have the highest affinity for
Gas6, MERTK is more readily activated when exposed to Gas6 in the presence of PtdSer,
indicating that it has an important role in apoptotic cell clearance15.

4
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A)
Legend:
IgG-like – Immunoglobulin-Like Domain
Fbg – Fibronectin-Like Domain
TM – Transmembrane Domain

B)

Figure 1. MERTK Domains and Clustering. A) MERTK domains. B) Clustering of MERTK
as quantified by super-resolution ground-state depletion microscopy (GSDM). ‘Cell’ shows the
cell being imaged, ROI shows the area imaged at super-resolution. GSDM shows MERTK
clustering with ~20 nm resolution. Scale bars are 2 µm, image is shown as a heat-map. (Image
courtesy of Amanda Evans).
5
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Previous studies have already elucidated part of the overall TAM receptor signaling pathway.
Phosphorylation of the TKD domain of TAM receptors has been shown to result in activation of
the phosphotidoinsitide-3 kinase (PI3K)/Akt pathway32,35. After activation of the TAM receptor,
the SH2 domain of growth factor receptor-bound protein 2 (Grb2) binds to the tyrosine residue
immediately downstream of the TKD. Grb2 subsequently recruits the p85 and p110 subunits of
PI3K into a complex34,35. This complex then goes on to phosphorylate the lipid
phosphatidylinositol-4,5-biphosphate (PIP2) to form phosphatidylinositol-3,4,5-triphosphate
(PIP3), which in turn recruits and activates Akt34,35. Akt-associated substrates are known to
mediate a variety of important cellular processes including survival, proliferation, angiogenesis,
and autophagy36. TAM signaling has also been implicated in the resolution of inflammation via
inhibition of the Janus kinase (JAK)/ Signal transducer and activator of transcription (STAT)
pathway37–39. When dimerized, JAKS autophosphorylate and activate STAT proteins which act
as transcription factors for several genes involved in inflammatory responses37-39. TAM receptors
couple with Type I interferon receptor (IFNAR), with activation of the TAM-IFNAR complex by
Gas6 inducing the expression of suppressors of cytokine signaling-1 (SOCS1) and -3 (SOCS3)
which disrupt JAK-STAT interactions and reduce type I IFN activation40. It is unlikely this
pathway inhibits all forms of pro-inflammatory signalling known to be inhibited by TAM
receptors, as not all of these pro-inflammatory pathways require JAK-STAT signaling or signal
via IFNAR.

1.3

MERTK Signalling and Efferocytosis

In the context of efferocytosis, MERTK-mediated engulfment of apoptotic cells appears to
require the activation of integrin co-receptors such as αvβ5 integrin32,41,42. Integrins are
transmembrane receptors that conventionally mediate attachment of cells to the extracellular
matrix. However, some integrins are co-opted for processes such as phagocytosis and
efferocytosis. Efferocytic integrins have been shown to interact with exposed PtdSer via the
opsonin MFG-E843,44. MERTK and integrin co-activation has been proposed to involve the

6
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recruitment of Src proteins via autophosphorylation of the Tyr-867 residue which induces the
Src-mediated phosphorylation of focal adhesion kinase (FAK)32. Phosphorylated FAK is
subsequently recruited to the integrin where it induces formation of the p130cas/CrKII/Dock180
complex which stimulates efferocytosis-associated cytoskeletal remodelling via Ras-related C3
botulinum toxin substrate 1 (Rac1) GTPase activity32,41. Rac1 facilitates this remodeling by
promoting membrane ruffling and engulfment of the apoptotic cell via actin polymerization and
remodeling35,41. Another protein that may be involved in the activation of integrins during
efferocytosis is Ras-related protein 1 (Rap1), which has been observed to be associated with cell
adhesion and junction formation signaling pathways45. Various Rap1 effectors such as RAPL,
Riam45, and Krit146, are known to mediate integrin activity. Rap1 has also been shown to affect
Rac1-linked cell spreading and adhesion through interactions with Rac1 guanine nucleotide
exchange factors (GEF)47. Binding of Rap1 to these GEFs allows for the localization of Rac1
activity to areas of active cell spreading47. Additionally, Rap1 may also modulate the activity of
another GTPase called Ras homolog gene family, member A (RhoA) which is required for
efferocytosis48. Activation of RhoA can be induced by exposure to TNFα 49 or lysophosphatidic
acid (LPA)50. Binding of Rap1 to RhoA GTPase-activating proteins (GAP) appears to increase
the activity of RhoA51. Thus, Rap1 may play an important role in regulating the balance between
the Rac1 and RhoA-dependent mediation of integrin-associated engulfment of apoptotic cells48.
A specific association between MERTK and integrins, however, has not yet been observed in
phagocytic cell lines, and MERTK has even been reported to induce efferocytosis in the absence
of an integrin co-receptor in some cases32,42.
Our group demonstrated that MERTK is pre-structured in large complexes on the cell surface,
with recent evolution increasing the cluster size of human MERTK compared to our recent ape
and primate common ancestors (Fig. 1B). In this study we demonstrated that MERTK clustering
increases its affinity, which occurred concurrently with a downregulation of MERTK expression
- likely an adaptation to limit viral binding to MERTK without adversely affecting MERTK
function52. In recent work (Fig. 2), we have used reversible Cross-Link Immunoprecipitation
(ReCLIP) of HA-tagged MERTK expressed on Cos7 cells, followed by mass spectrometry, to
identify the contents of these MERTK clusters. This revealed potential elements of the MERTK
signalosome (Fig. 2A), including PI3K32,35, which is involved in large particle internalization,
and ERK28,29 and FAK32, which are involved in phagocytosis-associated cytoskeletal
7
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remodelling (Fig. 2B). In addition, Integrin β1 and ILK were also found in this analysis,
indicating the potential presence integrins and integrin-activating signalling molecules within
these clusters32,41,42 (Fig. 2B).

Figure 2. Identification of Elements of the MERTK Signalosome using ReCLIP. A) Cos7
cells expressing MERTK with an extracellular HA tag were treated with the ReCLIP protein
cross-linking reagent, and the MERTK signalosome precipitated from the resulting cell lysates
with anti-HA antibody. When resolved on a gradient SDS-PAGE gel multiple protein bands were
visible, and the indicated bands were sent for mass spectrometry to identify the MERTKassociated proteins. B) Putative MERTK interacting proteins identified from the corresponding
protein bands in panel A. Data courtesy of Angela Vrieze.

1.4

Clinical Relevance of MERTK

MERTK-facilitated efferocytosis notably appears to play a critical role in the development of
atherosclerosis, the most common form of cardiovascular disease74. Atherosclerosis is
characterized by the buildup of plaque in the sub-arterial space. This plaque is composed
primarily of cholesterol and lipid-filled apoptotic cells, and necrotic debris53. Plaque growth
8
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results in the stretching and weakening of the arterial wall, culminating in plaque rupture and
prompting the onset of thrombosis54. Acute thrombus can occlude blood vessels causing a
myocardial infarction (heart attack) or an ischemic stroke if the thrombus lodges in the heart,
brain or other tissues respectively. Cardiovascular disease is currently the second leading cause
of mortality in Canada after cancer55.
The primary process driving atherosclerotic plaque progression is the accumulation of
cholesterol-laden foam cells within the vascular intima. Foam cells are generated from
macrophages which take up large amounts lipoprotein-bound cholesterol from lipoproteins
deposited in the sub-vascular space. Foam cells begin as normal monocytes in the circulation;
modifications of lipoproteins in the vascular intima via processes such as oxidation and
enzymatic cleavage induce an immune response which facilitates the recruitment of these
circulating monocytes54. Cytokines and chemokines secreted by vascular endothelial cells then
promote adhesion of the monocytes to the vascular wall and their subsequent extravasation into
the subendothelial space54. These monocytes proceed to differentiate into macrophages which
take up oxidized low-density lipoprotein (oxLDL)-bound cholesterol molecules; the
modifications made to these lipids and cholesterol prevent their normal processes sing, leading to
accumulation in the macrophages. These lipids and cholesterol accumulate until the macrophages
until they are converted into foam cells. In addition to secreting molecular factors that promote
inflammation and degradation of the extracellular matrix, foam cells also undergo apoptosis due
to elevated endopasmic reticulum stress caused by cholesterol loading56,57. Normally
efferocytosis should clear these debris, but for unknown reasons this does not occur in the
plaque, leading to the accumulation of apoptotic cells, secondary necrosis, and eventually the
formation of a highly unstable necrotic core54.
While the exact reasons behind this ineffective clearance of apoptotic cells are still largely
unclear, deficiencies in MERTK function have been found to be associated with the buildup of
apoptotic cells and subsequent plaque necrosis in murine models. Apolipoprotein E-deficient
(Apoe -/-) mice expressing defective MERTK protein containing a truncated TKD that were fed a
high cholesterol diet, for example, exhibit larger atherosclerotic lesions composed of higher
amounts of uncleared apoptotic cells relative to control mice58. Decreased expression of MFGE8, which acts as an opsonin for MERTK’s integrin co-receptors, has also been linked to
9
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increased atherosclerosis severity59. In addition, low-density lipoprotein receptor deficient
(LDLR -/-) mice reconstituted with bone marrow from MFG-E8 -/- mice seem to possess larger
amounts of plaque necrosis, apoptotic cell accumulation, and IFN γ expression levels relative to
healthy controls60. In humans, SNPs in MERTK are associated with atherosclerosis, and
moreover, MERTK appears to be the main efferocytic receptor expressed by macrophages in the
heart61,62.
Despite MERTK’s well-established clinical importance, little is understood of the signaling
pathways utilized by MERTK to activate co-receptors, engulf apoptotic cells and mediate the
subsequent degradation of engulfed apoptotic cells. As such it is the goal of my thesis project to
elucidate MERTK signaling under homeostatic conditions and to identify MERTK-associated
signaling molecules involved in efferocytosis I hypothesize that the MERTK signaling
pathway will require integrins as co-receptors, and engage canonical phagocytic pathways
to mediate apoptotic cell internalization.
For the first objective of this project, signaling molecules of interest identified in the literature
and in Fig. 2 will be inhibited with pharmacological inhibitors in order to assess each molecule’s
role in the MERTK-mediated efferocytosis. The second objective of this project will be to
identify non-canonical intracellular signaling pathways utilized by MERTK in macrophages. The
data produced by this project will characterize MERTK-associated signalling pathways and
molecules and clarify the possible roles that they play in efferocytosis.

10
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Chapter 2

2

Materials and Methods

2.1

Materials

HA-MERTK construct was generated by Amanda Evans at our laboratory. Briefly, an
extracellular HA tag was added by linearizing our lab’s pEGFP-N1 MERTK vector using the
HA-FWD (5’ Phos–GGCGT AGTCA GGCAC GTCGT AAGGA TAGTC GGTCT GCAGG
CTTCC G), HA-REV 5’ ( 5’ Phos–CACAC ACCAC TGCTG TCACT G) PCR primers. PCR
was then conducted using Phusion DNA polymerase at 36 cycles with a 63°C annealing
temperature and an 8 minute elongation at 72°C. The resulting product was then treated with
DpnI for 1 hour to degrade the template and gel purified. The purified linearized construct was
then recirularized with T4 DNA liagase before being transformed into DH5α E. coli. Viable
clones were then selected for on agar plates containing ampicillin. Cos7 stably expressing our
HA-MERTK construct (HA-MERTK-Cos7) were generated by Angela Vrieze by subcloning the
HA-MERTK-Cos7 construct into a pLVX vector containing a selectable resistance marker for
G418 (Geneticin), transfecting the vector into Cos7 cells using Genjet, and selecting for viable
cells via G418 mediated selection. THP-1 cells were obtained from ATCC. Rosewell Park
Memorial Institute (RPMI) media was purchased from ThermoFisher Scientific. Dulbecco’s
Modified Eagle Medium (DMEM), and Fetal Bovine Serum (FBS) were purchased from Wisent.
Trypsin-EDTA and antibiotic/antimycotic was purchased were purchased from Corning. 16%
Paraformaldehyde (PFA) and #1.5mm thickness coverslips were purchased from Electron
Microscopy Supplies (Hatfield, Pennsylvania). Rat high-affinity anti-HA antibody clone 3F10
was purchased from Sigma-Aldrich (Oakville, Canada). Anti-phosphotyrosine (4G10) antibody
was purchased from EMD-millipore. PP1, Syk Inhibitor, Ly294002, Wortmannin, Cpd22, and
U0126 inhibitors were purchased from Cayman Chemical. Phorbol 12-Myristate 13-Acetate
(PMA) was purchased from Bioshop Canada. Polystyrene-DVB beads were purchased from
Bangs Laboratories. Mouse IgG antibody was purchased from Invitrogen. Recombinant human
Gas6 (rhGas6) was purchased from R&D Biosystems. Guide RNA, donor DNA, and Cas9
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protein were purchased from Sigma-Aldrich. Prism software was purchased from GraphPad.
ImageJ was downloaded from www.imagej.nih.gov/ij/ respectively.

2.2

THP-1 Culture and Differentiation

THP-1 cells were maintained in RPMI containing 10% FBS in T25 flasks at 37°C and 5% CO2.
Cells were passaged upon reaching a density of 2,000,000 cells/ml. Prior to passage, cells were
counted using a hemocytomer and a volume of media containing 1,000,000 cells was removed
and placed in a 15 mL Falcon tube. The cells were then washed twice with 1 ml of phosphatebuffered saline (PBS) by centrifuging cells and discarding the supernatant. Cells were then
resuspended in 5 ml of RPMI media pre-warmed to 37°C and placed in a new T25 flask for a
final density of 200,000/ml. For experiments, #1.5 thickness 18 mm diameter circular coverslips
were placed in wells of a 12 well plate and a volume of media containing 200,000 cells was
aliquoted into each well containing a coverslip. Pre-warmed RPMI media was added to each well
if necessary to bring the total volume of media in each well to 1 ml. PMA was then added to
each well at a concentration of 100 ng. Cells were then allowed to differentiate into a
macrophage-like phenotype for 3 days prior to the beginning of the experiment.

2.3

HA-MERTK-Cos7 Culture

HA-MERTK-Cos7 cells were maintained in DMEM containing 10% FBS in T25 flasks at 37°C.
Cells were subculture upon reaching 90% confluency by washing with PBS before being
incubated for 5 mins with trypsin-EDTA followed by suspension in DMEM + 10% FBS. #1.5 18
mm coverslips were placed in the wells of a tissue culture plate, 1 mL of DMEM + 10% FBS
added to each well, and then 100 μl of cell suspension added dropwise to each well. Cells were
cultured for 24 hours at 37°C prior to the beginning of the experiment.

2.4

Efferocytosis Assays

THP-1 cells were prepared and differentiated as indicated in section 2.2 3 days prior to the
beginning of the experiment. 10 μl of polysterine beads were suspended in PBS in a 1.5 ml
falcon tube and opsonized with 10 μl of either IgG or Gas6 for 24 hrs at 4°C on a rotating
12

Elucidation of the Signaling Pathway of MERTK

Kyle Taruc

platform prior to the beginning of the experiment. On the day of the experiment, the opsonized
beads are blocked with blocking buffer (5% BSA + PBS) for 20 mins, washed and resuspended
in PBS. The cells were then incubated with a few crystals (~0.05 mg) of biotin for another 20
mins, washed with PBS, and resuspended in 100μl PBS. THP-1s were incubated at 37°C with the
indicated concentration of the pharmacological inhibitors for at least 20 mins before the
beginning of the experiment. 5 μl of opsonized beads are then added to the wells containing cells
and the well plate is centrifuged at 1500 rpm for 1 min to allow the cells to come into contact
with the beads. The cells were then incubated at 37°C to allow for internalization of the beads.
After incubation, cells were washed 3x with PBS before being stained with 1:20,000 Hoescht
33342 and streptavidin for 10 mins. Cells were then washed 3x with PBS once more before
being fixed in 4% paraformaldehyde (PFA) and mounted on coverslips using Permafloor
mounting reagent. Imaging of cells was carried out using a Leica DMI6000 widefield
microscope equipped with 63×/1.40NA and 100×/1.40NA objectives, a heated/CO2 perfused
stage, Chroma Sedat Quad filters, a Photometrics Evolve 2 Em-CCD camera, operated by Leica
LAS-X software. Images were captured in which light (DIC) and in the indicated fluorescence
channels, exported to ImageJ and % efferocytic efficiency was calculated by dividing the total
amount of macrophages internalizing at least 1 (unstained) bead divided by the total number of
macrophages multiplied by 100.

2.5

Immunoblot

HA-MERTK-Cos7 cells were prepared as outlined in section 2.3 and seeded onto 6-well plates.
Cells were serum-starved for 5 hours prior to the beginning of the experiment. Cells were then
cross-linked with 1:1000 high affinity rat anti-HA antibody for 20 mins before being crosslinked with 1:10,000 goat anti-rat Cy3 secondary antibody and 1:10,000 rabbit anti-goat Cy3
tertiary antibody for 20 mins each. Cells were lysed with Lamelli buffer (4% SDS, 20% glycerol,
10% 2-mercaptoethanol, 0.004% bromphenol blue and 0.125 M Tris HCl, pH 6.8) plus
protease/phosphatase inhibitor cocktail, PMSF, NaF, and sodium orthovanadate before being run
on a 10% SDS PAGE gel at 100 V for 2 hours. Samples were then transferred to nitrocellulose
membranes at 4 degrees Celsius for 2 hours at 80 V. The membrane was then blocked for 2 hrs
with 5% BSA in TBST before being treated with 1:1000 4G10 anti-phosphotyrosine primary
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antibody for 2 hours, washed 3X with TBST, incubated with 1:10,000 IR700 anti-mouse
secondary antibody, and washed another 3X with TBST. Blots were imaged using a LI-COR
Odyssey GelDoc.

2.6

Imunomprecipitation

HA-MERTK-Cos7 cells were prepared as outlined in section 2.3 and seeded onto 100 mm x 20
µM tissue culture dish. Cells were serum-starved for 3 hours prior to the beginning of the
experiment. Cells were then cross-linked with 1:1000 high affinity rat anti-HA antibody for 20
mins before being cross-linked with 1:10,000 goat anti-rat Cy3 secondary antibody and 1:10,000
rabbit anti-goat Cy3 tertiary antibody for 20 mins each. Cells were then then lysed with RIPA
buffer plus protease/phosphatase inhibitor cocktail, PMSF, NaF, and sodium orthovanadate.
Lysates were subsequently incubated for 4 hours with agarose phosphotyrosine beads before
being washed 3x with wash buffer and 2x with PBS. Supernatant was then removed, and beads
were resuspended in 70 μl of phenyl phosphate. Beads were then centrifuged, and the resulting
supernatant was removed. DTT and Lammeli buffer (4% SDS, 20% glycerol, 10% 2mercaptoethanol, 0.004% bromphenol blue and 0.125 M Tris HCl, pH 6.8) was then added to the
supernatant and the solution was run on a 10% SDS-PAGE gel at 100V for 2 hours. The gel was
then fixed with a solution containing 50% methanol and 10% acetic acid and subsequently
stained with Coomassie Blue staining solution for 2 hours. The gel was then submerged in water
to allow it to destain for 24 hours. Gels were then imaged using a BioRad GelDoc EZ Imager.

2.7

CRISPR-Cas9

cRNA, tracrRNA, Cas9 protein, and a donor DNA template containing the HA-tag were
electroporated into THP-1 cells using the Neon electroporation system. 48 hours after
electroporation, cells were immunostained with an anti-HA antibody and a Cy3 secondary
antibody in order to assess surface expression of the HA-tag. Cells were then sorted using a
FACSIII Aria Cell Sorter and any HA-expressing cells identified were cultured. The cRNA and
donor DNA target sequences are described in the results section.
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Statistical Analysis

Unless other wise noted, one-way ANOVA with Tukey correction was used for all analyses.
Data associated with a p-value < 0.05 was considered significant. All statistical analyses were
conducted using GraphPad Prism software.
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Chapter 3

3

Results

3.1

Canonical Phagocytic Pathways

Efferocytosis assays were performed on PMA-differentiated THP-1 macrophages using our
laboratory’s established efferocytosis assay protocols63 with or without inhibitors against
canonical efferocytic/phagocytic signaling molecules. This included inhibitors against proteins
proposed to be involved in MERTK’s signaling pathway such as Src53,64, PI3K64,65, and Syk53, as
well as non-canonical signaling molecules that have been identified by our lab (Fig. 2) to be
associated with the MERTK signalosome such as ILK and ERK. For these experiments, THP-1derived macrophages were used, as these cells are known to exhibit substantially increased
MERTK expression upon PMA-differentiation and do not express any other members of the
TAM receptor family75, thus allowing us to use Gas6-coated beads as MERTK-specific targets.
As a positive control, to demonstrate the inhibitors were functional, the phagocytic uptake of
IgG-coated beads was assessed. IgG-mediated phagocytosis is known to be blocked by the
inhibitors used in these experiments66. For all inhibitors, phagocytosis/efferocytosis was
measured as phagocytic or efferocytic efficiency (% of Mφ (macrophages) with ≥ 1 bead
internalized).
Syk inhibition was found to significantly decrease phagocytic efficiency for both IgG and Gas6coated beads, while unexpectedly, Src inhibition was found to decrease phagocytic efficiency
only for macrophages exposed to Gas6 beads (Fig. 3). It is unclear why the Src inhibitor did not
block phagocytosis, as previous studies have found phagocytosis to be sensitive to the Src
inhibitor PP167. This difference may be due to PP1’s cross-reactivity with some serine/threonine
kinases; a cross-reactivity not reported for the SykI inhibitor used in this study. PI3K inhibition
via both LY294002 and Wortmannin was found to decrease phagocytic efficiency in
macrophages incubated with both IgG (Fig. 4) and Gas6 beads (Fig. 5). LY294002 specifically
inhibits the formation of PI(3,4,5)P3 at the cell membrane by Class I PI3K’s, whereas
wortmannin inhibits Class I PI3K’s, as well as Class II/III PI3K’s which are responsible for
producing PI(3)P and PI(3,4)P2, predominantly at endomembranes. The identical inhibitory
16
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response observed between LY294002 and wortmannin suggests that Class I PI3K activity is
required for efferocytosis via MERTK, consistent with previous studies32. Inhibition of ILK was
found to reduce efficiency in macrophages incubated with both IgG and Gas6 (Fig. 6) beads
while ERK inhibition was only found to decrease efficiency in macrophages incubated with
Gas6 beads (Fig. 6). These data indicate that MERTK-mediated efferocytosis utilizes many of
the same signalling pathways as Fc-mediated phagocytosis but does require some unique
signalling pathways not utilized for phagocytosis.
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Figure 3. Role of Src and Syk Kinases in MERTK-Mediated Efferocytosis. THP-1
monocytes were PMA-differentiated for 3 days prior to being subjected to an efferocytosis assay.
Uptake of A) IgG-opsonized, or B) Gas6-opsonized beads. Src was inhibited with PP1 (20mM)
and Syk with Syk-inhibitor I (SykI, 20mM) for 20 minutes before efferocytosis/phagocytosis
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assays were performed. n = 3. n.s. = P > 0.05, * = P < 0.05, compared with ANOVA with Tukey
correction.
A)
% P h a g o c y tic E ffic ie n c y

20

T H P 1 -Ig
T H P 1 -Ig -L y 2 9 0 0 4 2

15

10

5

*

0

B)
% P h a g o c y tic E ffic ie n c y

20

T H P 1 -Ig
T H P 1 -Ig -W o rtm a n n in

15

10

5

*

0

Figure 4. Role of PI3-kinases in Fc-Mediated Phagocytosis. PMA-differentiated THP-1 cells
were incubated with or without inhibitors of A) Class I PI3K (LY294002, 20mM) or B) Class I,
II and III PI3K (Wortmannin, 20mM). Inhibitors were added 20 minutes before phagocytosis
assays with IgG-coated beads were performed. n = 3. n.s. = P > 0.05, * = P < 0.05, compared with
ANOVA with Tukey correction.
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%Efferocytic Efficiency
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%Efferocytic Efficiency
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Figure 5. Role of PI3-kinases in MERTK-Mediated Efferocytosis. PMA-differentiated THP1cells were incubated with or without inhibitors of A) Class I PI3K (LY294002, 20 µM) or B)
Class I, II and III PI3K (Wortmannin, 20 µM). Inhibitors were added 20 minutes before
efferocytosis assays with Gas6-coated beads were performed. n = 3. n.s. = P > 0.05,
* = P < 0.05, compared with ANOVA with Tukey correction.
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Figure 6. Role of Erk and ILK in MERTK-Mediated Efferocytosis. PMA-differentiated
THP-1 were incubated with or without inhibitors of Erk (U0126, 20 µM) or ILK (Cpd22, 20 µM)
and A) phagocytic index of IgG coated beads, or B) efferocytic index of Gas6-coated beads
determined. Inhibitors were added 20 minutes before phagocytosis/efferocytosis assays. n = 3.
n.s. = P > 0.05, * = P < 0.05, compared with ANOVA with Tukey correction.
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MERTK Signaling Molecule Identification

Antibody cross-linking assays were used to identify specific elements of the MERTK signaling
pathway. Usage of MER-specific antibodies to activate signaling pathways is preferable to the
use of apoptotic cells, as these cells will be simultaneously recognized by all efferocytic
receptors on the responding cell, thus obscuring the MERTK-derived signals. However, of the
many commercial anti-human MERTK antibodies we have tested, only one which binds the
intracellular kinase domain of MERTK has been found to be functional (data not shown),
making this antibody unsuitable for cross-linking experiments. To address this problem, our lab
previously developed an HA-MERTK construct wherein an HA tag was inserted in a nonconserved domain located after the MERTK signal peptide (Fig. 7).

Figure 7. Structure of the HA-MERTK construct showing the location of the inserted HAtag. The HA tag was inserted in an evolutionarily non-conserved region between the N-terminal
signal peptide (Yellow) and Ig-like repeats (purple). Fgb/green = fibrinogen-like repeats; the
transmembrane domain is located between the Fbg and intracellular, c-terminal kinase domain
(red).

This HA-MERTK construct was then transfected into the Cos7 cell line, and expression
confirmed by anti-HA immunostaining (Fig. 8). Cos7 cells were used because, while not natively
phagocytic/efferocytic, the carry the molecular machinery required to perform such functions. As
reported previously, human MERTK was observed to form large clusters, some of which were
large enough to be resolved in these conventional microscopy images.

21

Elucidation of the Signaling Pathway of MERTK

Kyle Taruc

Figure 8. Expression of stably integrated HA-MERTK on the cell surface of Cos7 cells.
Fixed but non-permeabilized Cos7 cells were transfected with HA-MERTK and immunostained
with anti-HA and a Cy3-labeled secondary antibody. Left: DIC image, Right: anti-HA
immunofluorescence. Images are representative of 30 images taken over 2 independent
experiments.

Once MERTK expression was confirmed, another lab member prepared Cos7 cells stably
expressing this HA-MERTK construct (Fig. 8). Cross-linking and immunoprecipitation
experiments on this stable HA-MERTK-Cos7 cell line was carried out using full-length high
affinity anti-HA antibody, crosslinked by the addition of F(ab’)2 secondary and tertiary
antibodies (Fig. 9). F(ab’)2 antibodies are used for this cross-linking protocol because they lack
an Fc-portions and thus will be unable to bind to Fc-receptors on target cells, thereby preventing
the activation of non-MERTK specific signaling pathways. Prior to the cross-linking experiment,
cells are serum-starved for 3 hours in order to reduce basal signalling through growth factor
receptors. After antibody-mediated cross-linking was completed, the cells were lysed and
tyrosine-phosphorylated proteins precipitated using (4G10) anti-phosphotyrosine agarose beads,
followed by resolution of the immunoprecipitated using SDS-PAGE and Coomassie Blue
staining.
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Figure 9. Schematic of the method for identifying MERTK-activated signaling molecules.
HA-MERTK is activated by crosslinking with an anti-HA antibody and cross-linking
secondary/tertiary F(ab’)2 antibodies. Tyrosine phosphorylated proteins are immunoprecipitated,
resolved with SDS-PAGE and identified by mass spectrometry.

Cross-linking of HA-MERTK on these cells induced a strong and reproducible pattern of protein
phosphorylation, which could readily be detected by immunoblotting with the antiphsophotyrosine 4G10 antibody (Fig 10). However, we were unable to immunoprecipitate these
phosphorylated proteins using the same 4G10 antibody conjugated to agarose beads (Fig. 11).
Coomassie staining of gels containing cell lysates and bead wash supernatants suggest that the
precipitated proteins are either being degraded soon after incubation with the 4G10 beads or are
being lost during the wash steps (Fig. 11).
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Figure 10. Detection of phosphotyrosine signaling following MERTK cross-linking. Antiphosphotyrosine (4G10) immunoblot of HA-MERTK-Cos7 cells that are either non-crosslinked
(lane 2) or cross-linked with an anti-HA antibody and F(ab’)2 secondary and tertiary antibodies
(lane 3). Lane 1 is the protein ladder. Gel is representative of 3 independent experiments.
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Figure 11. Loss of proteins during 4G10 immunoprecipitation. Proteins precipitated from
cross-linked HA-MERTK-Cos7 cells were tracked during 4G10 immunoprecipitation by SDSPAGE and coommassie staining. Lane 1: Ladder, Lane 2: non cross-linked HA-MERTK-Cos7
(total cell lysate), Lane 3: cross-linked HA-MERTK-Cos7 (total cell lysate), Lane 4: postimmunoprecipitation cell lysate (including 4G10 beads) from non cross-linked HA-MERTKCos7 cells, Lane 5: post-immunoprecipitation cell lysate (including 4G10 beads) from crosslinked HA-MERTK-Cos7 cells, Lane 6: wash buffer after first wash of non cross-linked HAMERTK-Cos7 4G10 precipitates., Lane 7: wash buffer after first wash of cross-linked HAMERTK-Cos7 4G10 precipitates, Lane 8: proteins precipitated from non cross-linked HAMERTK-Cos7 after 1 wash, and Lane 9: proteins precipitated from cross-linked HA-MERTKCos7 after 4 washes. Image is representative of 12 independent experiments.
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Moving Towards a Better MERTK Experimental System

While Cos7 and THP-1 monocytes have been used for our analyses, both cell types have
drawbacks. Cos7 cells are non-human cells which are not intrinsically efferocytic, and therefore
may form aberrant MERTK clusters that differ in their composition from what is found on
human cells. Similarly, while THP-1’s express MERTK, the absence of quality antibodies
recognizing the extracellular potion of human MERTK and the presence of other efferocytic
receptors, limits our ability to selectively engage and isolate MERTK in these cells. We have had
great difficulty in expressing HA-MERTK ectopically in THP-1 cells, and moreover, our
previous study of MERTK clustering52 suggests that MERTK clustering – and therefore
signalosome composition – may be highly dependent on the expression level of MERTK, thus
making over-expression systems inappropriate for studies of the MERTK signalosome. We are
therefore currently attempting to use the CRISPR-Cas9 genome editing platform to generate a
stably-transfected THP-1 cell line that constitutively expresses HA-MERTK. Briefly, this
technology involves the generation of a CRISPR guide RNA containing a sequence matching
that of the target DNA sequence on the genome of interest. Cas9 endonuclease then recognizes
this sequence on the CRISPR guide RNA and begins cutting all matching sequences on the
genome of interest. A donor DNA containing the sequence that is to be inserted at the cut sites
can subsequently be introduced and used as a template for repair, effectively inserting a new
sequence at the genetic loci of the original. Our first approach aims to induce a double-stranded
break in the MERTK loci near the region where the HA-tag is introduced in our complex; a
repair template, containing the HA tag and ~60 bp of homology surrounding the cut site, is
introduced at the same time as the Cas9 riboprotein complex, in the hopes that homologous DNA
repair will use this template to fix the Cas9-induced DNA break (Fig. 12A). To improve our
chances of success we have designed two different donor DNAs (single and partially-double
stranded versions) containing the HA-tag, as well as two guide RNAs (gRNAs) designed by
Sigma-Aldrich which we complex with Cas9 and tracrRNA to form functional riboprotein. The
donor DNAs and riboprotein complexes were electroporated into the THP-1 cells using the Neon
electroporation system and HA-MERTK expressing cells are sorted via flow cytometry. Our
early attempts at these experiments produced a small number of cells which appeared to be
positive for HA-MERTK by immunofluorescence microscopy (Fig. 12B), and while a similar
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population can be separated by FACS sorting, subsequent testing failed to identify HA-MERTK
in these cells (Fig. 13).
A)

B)

Figure 12. CRISPR-Cas9 mediated integration of an HA-tag at the THP-1 MERTK locus.
A) The two guide RNAs (gRNA 1 & 2) bind 5’ of the desired HA insertion site (green). The
Cas9-RNA ribonuclear complexes should cut the DNA within the PAM site at the 5’ end of each
gRNA (yellow). Following homologous DNA repair, using a donor DNA template containing
the HA tag flanked on either side by 30 bp of either single or double-stranded DNA, the HA tag
should be permanently incorporated into the endogenous MERTK locus. B) cRNA, tracrRNA,
Cas9 protein, and a donor DNA template containing the HA-MERTK-Cos7 sequence were
electroporated into THP-1 cells using the Neon electroporation system. 48 hours after
electroporation, cells were immunostained with an anti-HA antibody and a Cy3 secondary
antibody in order to assess surface expression of the HA-tag. The cells in this image were
transfected using gRNA 1 and donor DNA 1. Images were captured using an HKD Leica
Widefield Microscope. Scale bar = 10 μm.
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Figure 13. Flow cytometry sorting of CRISPR-edited THP-1 cells. THP-1 cells, edited with
CRISPR to add an HA tag to the extracellular domain of MERTK, were immunolabeled with
anti-HA and sorted by FACS. While a small portion of cells were positive for HA-MERTK (HA
pos/red), these cells did not remain viable after recovery.

To resolve the issues associated with the CRISPR-Cas9 mediated transfection of THP-1
monocytes with our HA-MERTK construct, our laboratory is investigating the viability of the
CRISPaint variation of this system68. CRSIPaint uses non-homologous end-joining to promote
the insertion of a gene at a specific locus and has been successfully used to modify THP-1 cells.
CRISPaint relies on the transfection of three plasmids; the first plasmid expresses the guide RNA
and Cas9, the second plasmid is the donor vector and contains the sequence to be inserted into
the genome, while the third plasmid contains a gRNA sequence that allows Cas9 to linearize the
donor vector such that the inserted sequences is in-frame68. Aside from the fact that this method
takes advantage of non-homologous end-joining machinery to promote precise DNA template
insertion and repair at the genetic loci of interest, the 3 aforementioned DNA/gRNA plasmids
employ minicircle technology, which allows for the removal of unnecessary prokaryotic
elements from the donor plasmid resulting in a reduction in overall plasmid size and
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subsequently improves plasmid uptake by cells68. At the time of this thesis we have identified a
gRNA which cleaves 3 base-pairs before the MERTK start codon
(AATTACAGATCCGCAGCCCCGGG) and have begun cloning HA-MERTK into the donor
DNA vector. Once complete, this vector set should allow for us to insert our HA-MERTK
construct into the translational start site of the endogenous MERTK locus, thus producing HAMERTK-THP-1 cells expressing MERTK under control of the endogenous promotor.
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Chapter 4

4

Discussion

In this thesis I tested the hypothesis that MERTK mediates efferocytosis through canonical
phagocytic signaling pathways. I successfully identified several signaling pathways required for
efferocytosis through MERTK. These included the canonical phagocytosis signaling molecules
Src-family kinases, Syk and PI3K, but also included the non-canonical signaling molecules Erk
and ILK, indicating that MERTK-mediated efferocytosis occurs via a unique signalling pathway
that is only partially shared by phagocytosis. I also developed a cross-linking based assay that
was able to specifically induce phosphotyrosine signaling following MERTK cross-linking.
While I was not able to identify any of the activated signaling molecules, this platform can be
used in the future to determine whether Rap1 and/or SOCS1/3 are activated downstream of
MERTK. Lastly, I have begun the development of a new cell-based system for studying MERTK
function. This new system offers several advantages over the model system used to-date;
specifically, it allows for the selective activation of MERTK via HA-mediated cross-linking, in a
relevant human efferocytic cell type that normally expresses MERTK. Combined, my thesis has
provided a preliminary assessment of the signalling lying downstream of MERTK activation and
has laid the groundwork for future mass spectrometry and cell signaling studies into MERTK
function.
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4.1 Role of Canonical Phagocytic/Efferocytic Pathways in MERTKMediated Efferocytosis
As expected, inhibition of PI3K prevented both MERTK-efferocytosis and phagocytosis, as
PI3K is well-known to be involved in large particle internalization by phagocytes64,65.
Specifically, PI3K enables the large-scale actin reorganization required for large-particle
internalization. In phagocytic studies, small (<1 µm) particles do not require PI3K activity for
their uptake; it is unclear at this time whether this is true for MERTK as I only assessed
efferocytosis using large (5 µm) particles whose uptake was predicted to require PI3K. Src and
Syk are known membrane-proximal regulators of phagocytic signaling, with phagocytic
receptors directly activating Src, which in-turn recruits and activates Syk to mediate actin
cytoskeleton polymerization through proteins such as VAV153,64. Specifically, the Src/Syk
signaling pathway signals via immunoreceptor tyrosine-based activation motifs (ITAMs) which
are found in most phagocytic receptors, and which must be phosphorylated to initiate the
phagocytic process64. Curiously, while both Src and Syk inhibition were shown to decrease
efferocytic efficiency in THP-1 cells, a greater decrease was observed for Syk inhibition as
opposed to Src inhibition, despite the fact that Syk is activated by Src. This may have been due
to better inhibition of Syk then of Src; indeed, we used a newly developed and high affinity
inhibitor for Syk, versus a lower-affinity and reversible agent for Src inhibition. Phagocytosis –
both of antibody and complement opsonized targets - also requires ILK, with my data indicating
that MERTK likewise requires this signaling molecule. During phagocytosis, ILK mediates the
activity of integrins, which are required to exclude inhibitory signalling molecules during Fcmediated phagocytosis and which can independently mediate the uptake of complementopsonized targets69. Consistent with this, we observed a decrease in phagocytic efficiency that
accompanies ILK inhibition. It is unclear what ILK is doing in our system, as no integrin ligands
were present on our Gas6 beads. Some studies have proposed that ILK independently promotes
cytoskeletal remodelling through by activating Rac1, and this may account for the role of ILK in
our model system70; alternatively, Gas6 may be recognized by a promiscuous integrin such as
Mac1. Combined, these inhibitor studies demonstrate that the PI3K, Src, Syk and ILK pathways
are required for MERTK-mediated uptake, indicating that MERTK employs much of the same
molecular machinery for target internalization as does canonical Fc-mediated phagocytosis. This
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is unsurprising as the uptake of large particulates requires large-scale, complex reorganisation of
the actin cytoskeleton. The signaling mediating this reorganization during phagocytosis is deeply
conserved, having first evolved in single celled amoebas, with the more recent evolution of
efferocytosis apparently coopting this previously evolved pathway.
While most of the pathways I identified as mediators of MERTK efferocytosis, one noncanonical signaling molecule – ERK – was identified as indispensable for MERTK function.
ERK has a less defined role in phagocytosis, with some studies showing a weak but significant
reduction in FcyR-mediated phagocytosis in ERK-inhibited neutrophils and macrophages71,
while other studies and this thesis have demonstrated ERK to be dispensable for phagocytosis
Like ILK, ERK has also been shown to be involved in Rac1-mediated cytoskeletal remodeling,
although it is unclear if these pathways activate Rac1 via the same signaling pathways71.
Critically, in this thesis, I found that ERK inhibition profoundly blocked MERTK-mediated
efferocytosis, but had no effect on Fc-mediated phagocytosis, indicating that MERTK has
evolved some unique signaling pathways not utilized by phagocytic receptors. This further
validates our goal of fully elucidating the MERTK signalling pathway, as the presence of noncanonical signaling pathways offers the opportunity to selectively target efferocytosis without
significantly altering other internalization processes. One confounding issue in these assays was
a lower-than-expected uptake of particles under control conditions; an issue which may be
addressed in future experiments through increasing the target:macrophage ratio and/or increasing
the experiment time. Additionally, off-target effects associated with the inhibitors used in these
experiments may have played a role in the observed discrepancy in particle uptake, an issue that
could be investigated by performing further efferocytosis assays using siRNAs directed against
the same molecules targeted by the inhibitors.

4.2 Clinical Implications of Deficiencies in MERTK-Mediated
Efferocytosis
Future studies regarding the signaling pathways associated with MERTK-mediated efferocytosis
will not only likely be aimed at identifying novel signaling molecules but also their roles in
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clinical conditions such as atherosclerosis. Experiments aimed at investigating MERTK’s role in
this disease could involve culture of macrophages in atherosclerotic conditions (i.e. high
oxLDL), followed by assessment of the activation of previously identified MERTK-associated
signaling molecules, to determine the source of MERTK defects in atherosclerosis. If the
expression or phosphorylation levels of these signaling molecules are found to be dysregulated
under atherosclerotic conditions, normal levels could be restored and their effects on the
efferocytic ability of the macrophages measured. The data produced such studies will
characterize MERTK-associated signalling pathways and molecules and clarify the possible roles
that they play in the mediation of efferocytosis. Additionally, the results of such data may also
increase understanding of MERTK’s role in the development of atherosclerosis and allow for
identification of putative targets for treatment of this disease.

4.3

Limitations of the MS/MS Model

Optimization of the immunoprecipitation-mass spectrometry method of identifying potential
MERTK-associated signaling proteins presents another significant challenge, as activated
signaling molecules either become degraded or are lost when the lysates are washed. The source
of this issue remains unclear, as indeed, our lab has successfully used this approach
previously72,73. There are two likely causes of this issue; first, the commercially purchased 4G10
agarose may have been non-functional. This seems unlikely as we tested two lots of this reagent,
with both failing to precipitate any proteins. However, direct (chemical) antibody conjugation to
beads has the potential to inactivate antibodies, and thus may account for our failure to
precipitate proteins. To address this issue, we will use protein A/G beads to precipitate 4G10 in
the future; while this makes subsequent detection of proteins more difficult (due to the presence
of the antibody in the precipitate), it would resolve any issues with antibody inactivation during
crosslinking to beads. Alternatively, we may have failed to fully inhibit cellular phosphatases,
and thus lost the 4G10 target motif (phosphotyrosine). We are in the process of testing
phosphatase inhibitor cocktails from other companies, in the hopes of identifying a better
reagent.
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Moving Towards an Endogenous MERTK Expression System

Moving forward, the optimal system in which to study MERTK signaling would be in a human
cell line that expresses our HA-MERTK construct under control of the endogenous MERTK
locus. Given that human MERTK has been shown to cluster on the cell surface differently than
its primate counterparts, any study of signaling based around using human-based cell lineages
would provide more biologically relevant results as opposed to those obtained from primate cell
lineages such as Cos7. In addition, endogenous expression of the receptor would allow for
expression levels similar to those observed physiologically, with transgene-mediated
overexpression promoting aberrant clustering and potentially altered function of MERTK. Thus,
CRISPR-mediated gene editing of the endogenous MERTK locus in THP-1 cells represents a
better model system. As outlined in Section 3.3 however, CRISPR-Cas9 mediated insertion of
HA-MERTK into the genome of the human monocyte cell line THP-1 has so far been
unsuccessful as flow cytometry sorts of edited samples do not return a significant number of HApositive cells. The use of the CRISPaint variation of the CRISPR-Cas9 technique however, may
yet yield more favorable results, as its usage of minicircle technology and non-homologous endjoining DNA repair may improve both delivery of the gRNA/DNA plasmids into the cell and the
insertion of the DNA template sequence into the genome respectively.
In conclusion, in this thesis I determined that MERTK mediated efferocytosis is dependent on
the canonical Src-Syk-PI3K-ILK phagocytic signaling pathway but has also evolved to require
the non-canonical ERK signalling pathway. This work provides the first study of the role of these
pathways in mediating the internalization of efferocytic targets by MERTK and lays the
groundwork for continuing investigation into the signaling pathways regulating MERTKmediated efferocytosis and the downstream cellular events which follow efferocytosis.
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